Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

The purpose of the study is to demonstrate the efficacy, safety and tolerability of rozanolixizumab compared with placebo in the treatment of adult study parti…

Ocular Myasthenia Gravis

Estimated

~$10 – $8,750

UCB Biopharma SRLNCT07463521